Cantor Fitzgerald analyst Richard Anderson raised the firm's price target on Healthcare Realty Trust to $21 from $19 and keeps an Overweight rating on the shares. Healthcare Realty Trust delivered a strong Q4 and full year 2025, highlighting structural improvements in process, people, earnings potential, and the balance sheet, the analyst tells investors in a research note. Same-store NOI growth, occupancy gains, and a 2026 FFO outlook slightly above expectations suggest stable core growth while providing potential upside from asset sales and deleveraging, the firm says.
